Pharmacokinetics study of Donepezil HCl in subjects receiving haemodialysis.

Status

Unknown

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1080221230

Enrollment

Registered

2010-09-03

Start date

2010-09-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Failure

Interventions

investigational material(s) Generic name etc : E2020 INN of investigational material : Therapeutic category code : 119 Other agents affecting central nervous system Dosage and Administration for Inve

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -end-stage renal disease who were receiving haemodialysis. -Subject who are able and willing to give written informed consent.

Exclusion criteria

Exclusion criteria: -Subjects with known hypersensitivity to drugs or foods. -Subjects with a corrected QT interval greater than 450msec at screening period.

Design outcomes

Primary

Measure	Time frame
Pharmacokinetics parameters	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026